Ιn a world first, the UK medicines regulator has approved a therapy that uses the CRISPR–Cas9 gene-editing tool as a treatment. The therapy, called Casgevy, will treat the blood conditions…
Ιn a world first, the UK medicines regulator has approved a therapy that uses the CRISPR–Cas9 gene-editing tool as a treatment. The therapy, called Casgevy, will treat the blood conditions…